CCND3 POSITIVE

Clinical trials for CCND3 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CCND3 POSITIVE trials appear

Sign up with your email to follow new studies for CCND3 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing a combination of two drugs, ibrutinib and rituximab, for people with mantle cell lymphoma, a type of blood cancer. It is for two groups: those whose cancer has returned or hasn't responded to prior treatment, and older patients newly diagnosed with the disea…

Matched conditions: CCND3 POSITIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

CCND3 POSITIVE

Get alerted when new CCND3 POSITIVE trials appear

New drug combo tested for Tough-to-Treat blood cancer